{"id":8020,"date":"2023-04-21T17:12:38","date_gmt":"2023-04-21T15:12:38","guid":{"rendered":"http:\/\/www.seventure.fr\/wp-content\/uploads\/2023\/04\/20230420_Tubulis_BMS-PR_final.pdf"},"modified":"2023-04-21T17:12:38","modified_gmt":"2023-04-21T15:12:38","slug":"20230420_tubulis_bms-pr_final","status":"inherit","type":"attachment","link":"https:\/\/www.seventure.fr\/en\/tubulis-announces-strategic-license-agreement-with-bristol-myers-squibb-to-develop-next-generation-adcs-for-the-treatment-of-cancer-patients\/20230420_tubulis_bms-pr_final\/","title":{"rendered":"20230420_Tubulis_BMS PR_final"},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false},"class_list":["post-8020","attachment","type-attachment","status-inherit","hentry"],"acf":[],"yoast_head":"\n